Biogen Inc. Announces Board and Executive Changes
Ticker: BIIB · Form: 8-K · Filed: Jan 15, 2025 · CIK: 875045
| Field | Detail |
|---|---|
| Company | Biogen Inc. (BIIB) |
| Form Type | 8-K |
| Filed Date | Jan 15, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0005, $400,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-of-directors, appointments, departures
Related Tickers: BIIB
TL;DR
Biogen shakes up board, names new exec; Sandage out, Singhal in.
AI Summary
Biogen Inc. announced on January 13, 2025, changes in its board of directors and executive compensation. Specifically, Dr. Al Sandage, Jr. resigned from the Board of Directors, and the company appointed Dr. Priya Singhal as Executive Vice President, Head of Global Product Strategy and Commercialization. The filing also details updates to the company's compensatory arrangements for its named executive officers.
Why It Matters
Changes in board composition and executive leadership can signal shifts in company strategy or operational focus, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Executive and board changes, especially resignations, can introduce uncertainty regarding future strategy and leadership stability.
Key Players & Entities
- Biogen Inc. (company) — Registrant
- Dr. Al Sandage, Jr. (person) — Resigned Director
- Dr. Priya Singhal (person) — Appointed Executive Vice President
- January 13, 2025 (date) — Date of earliest event reported
FAQ
Who resigned from Biogen's Board of Directors?
Dr. Al Sandage, Jr. resigned from the Board of Directors.
What is Dr. Priya Singhal's new role at Biogen?
Dr. Priya Singhal has been appointed Executive Vice President, Head of Global Product Strategy and Commercialization.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is January 13, 2025.
What other items are covered in this 8-K filing besides director and officer changes?
The filing also covers the election of directors and compensatory arrangements of certain officers.
In which state is Biogen Inc. incorporated?
Biogen Inc. is incorporated in Delaware.
Filing Stats: 859 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2025-01-15 08:00:18
Key Financial Figures
- $0.0005 — ange on which registered Common Stock, $0.0005 par value BIIB The Nasdaq Global Se
- $400,000 — ts. Ms. Godbout's base salary will be $400,000 and he is eligible to participate in th
Filing Documents
- d830064d8k.htm (8-K) — 22KB
- g830064g1028031449905.jpg (GRAPHIC) — 2KB
- 0001193125-25-006578.txt ( ) — 145KB
- biib-20250113.xsd (EX-101.SCH) — 3KB
- biib-20250113_lab.xml (EX-101.LAB) — 17KB
- biib-20250113_pre.xml (EX-101.PRE) — 11KB
- d830064d8k_htm.xml (XML) — 3KB
Signatures
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Biogen Inc. By: /s/ Wendell Taylor Wendell Taylor Secretary Date: January 15, 2025 - 3 -